BioCentury | Nov 9, 2018
Distillery Therapeutics

Cancer

...lymphocytic leukemia (CLL) and Phase I/II testing to treat myelodysplastic syndrome (MDS). Sumitomo also has TP-1287...
BioCentury | Mar 20, 2018
Distillery Therapeutics

Cancer

...and chronic lymphocytic leukemia (CLL) and preclinical testing for myelodysplastic syndrome (MDS). Sumitomo also has TP-1287...
Items per page:
1 - 2 of 2